✦ LIBER ✦

Treatment of hepatic encephalopathy with rifaximin: More to think about

✍ Scribed by Norman Gitlin

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 632 KB
Volume: 53
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24112

No coin nor oath required. For personal study only.

✦ Synopsis

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.